CompletedNot Applicable

Incidence of Colonization by Multidrug-resistant Organisms in Mechanically Ventilated Patients With Severe COVID-19

Italy435 participantsStarted 2020-10-01

Plain-language summary

Retrospective single-center cohort study to evaluate the incidence of colonization by multidrug-resistant organisms (MDRO) in mechanically ventilated patients admitted to a large intensive care unit (ICU) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during the second wave of COVID-19 pandemic (October 2020-May 2021) in Lombardy, Italy. As secondary outcomes, the study evaluates the overall incidence of infections during the ICU stay and assesses the risk factors associated to bacterial superinfection and MDRO colonization.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * COVID-19-related respiratory failure * Mechanical ventilation at least 48 hours Exclusion Criteria: * Age \< 18 years * ICU stay \< 48 hours Concurrent participation in other clinical trials is not a criterion for exclusion from this study

What they're measuring

Incidence of MDRO colonization

Timeframe: 1000 patient days

Trial details

NCT IDNCT05293418

SponsorFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-05-30

View on ClinicalTrials.gov More COVID-19 trials